Fate Therapeutics
Price & Volume
Stats
See moreOpen | $1.25 |
Previous Close | $1.25 |
Day Range | $1.24-$1.59 |
52W Range | $0.91-$1.93 |
Market Cap | $145.3M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $6.6M |
Revenue Growth (YoY) | -26.4% |
Gross Profit (12 Mos) | -$85.2M |
Diluted EPS | -$1.15 |
News
See moreYahoo Finance • last month
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed
Yahoo Finance • 2 months ago
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Yahoo Finance • 5 months ago
Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference
About
CEO | Dr. Bahram Valamehr M.B.A., Ph.D. |
Address | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 161 |